Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meixiao Zhan

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Journal of Nanobiotechnology|January 7, 2022
Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapyMeixiao Zhan, Xiangrong Yu, Wei Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2022
Self-Splittable Transcytosis Nanoraspberry for NIR-II Photo-Immunometabolic Cancer Therapy in Deep Tumor TissueLi Wang, Wei Jiang, Yanhong Su, et al.
Zhonghua Yi Xue Za Zhi|April 22, 2014
[Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma]Yan Zhao, Yong Li, Baoshan Hu, et al.
World Journal of Surgical Oncology|February 18, 2022
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cellsXiaoying Hou, Cong Du, Ligong Lu, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug deliveryShaojun Peng, Boshu Ouyang, Yongjie Xin, et al.
Cell Death & Disease|February 26, 2024
SPOP point mutations regulate substrate preference and affect its functionYanran Deng, Wenhao Ding, Kaize Ma, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Oncology Letters|October 16, 2019
POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinomaXu He, Hongfa Xu, Wei Zhao, et al.
Journal of Biomedical Nanotechnology|April 29, 2022
Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade FerroptosisWenjun Ni, Yongxiang Li, Lingxia Liang, et al.
Biochemical and Biophysical Research Communications|February 1, 2017
Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathwayMeixiao Zhan, Xiaohan Sun, Jinxiao Liu, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Journal of Nanobiotechnology|January 7, 2022
Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapyMeixiao Zhan, Xiangrong Yu, Wei Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2022
Self-Splittable Transcytosis Nanoraspberry for NIR-II Photo-Immunometabolic Cancer Therapy in Deep Tumor TissueLi Wang, Wei Jiang, Yanhong Su, et al.
Zhonghua Yi Xue Za Zhi|April 22, 2014
[Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma]Yan Zhao, Yong Li, Baoshan Hu, et al.
World Journal of Surgical Oncology|February 18, 2022
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cellsXiaoying Hou, Cong Du, Ligong Lu, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug deliveryShaojun Peng, Boshu Ouyang, Yongjie Xin, et al.
Cell Death & Disease|February 26, 2024
SPOP point mutations regulate substrate preference and affect its functionYanran Deng, Wenhao Ding, Kaize Ma, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Oncology Letters|October 16, 2019
POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinomaXu He, Hongfa Xu, Wei Zhao, et al.
Journal of Biomedical Nanotechnology|April 29, 2022
Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade FerroptosisWenjun Ni, Yongxiang Li, Lingxia Liang, et al.
Biochemical and Biophysical Research Communications|February 1, 2017
Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathwayMeixiao Zhan, Xiaohan Sun, Jinxiao Liu, et al.
Pageof 12